EPO and cancer: These include research on MT-1A, Epo, and Septin9 gene methylation for auxiliary diagnosis at the Cancer Hospital of the Chinese Academy of Medical Sciences (ChiCTR2400083525), which involved a model-verification cohort of 297 participants and a clinical validation cohort of 1429 participates.